Switching to Doravirine in cART-Experienced Patients: An Effective and Highly Tolerated Option With Substantial Cost Savings.

Autor: Lanting, Vincent R., Oosterhof, Piter, Ait Moha, Daoud, van Heerde, Roos, Kleene, Marie José T., Stalenhoef, Janneke E., de Regt, Marieke J. A., Vrouenraets, Saskia M. E., van den Berk, Guido E. L., Brinkman, Kees
Zdroj: JAIDS: Journal of Acquired Immune Deficiency Syndromes; Feb2024, Vol. 95 Issue 2, p190-196, 7p
Databáze: Complementary Index